The TOMMORROW study is a research study seeking to learn more about the earliest stages of Alzheimer’s disease (AD). This study is currently recruiting more than 5,000 healthy elderly participants in approximately 50 study centres in North America, Europe and Australia. The purpose of the study is twofold:
- To study a new investigational test to see if it can predict the genetic risk for developing memory problems due to AD by examining two specific genes—APOE and TOMM40.
The study has now finsiehd recruiting.